Adaptyv Bio
Switzerland - EpalingesBiotechnology
Focus: Adaptyv Bio is a Swiss-based biotech company focused on next-generation protein engineering and foundry capabilities, positioned in the oncology space.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
9+2 this month
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Should You Work at Adaptyv Bio?
AI assessmentBest suited for early-career scientists or platform-builders seeking foundational role in emerging biotech with execution risk.
Why Work Here
- Early-stage platform company with potential to build proprietary protein engineering technology with broad oncology applications
- Lean 7-person hiring footprint suggests flat organizational structure with direct access to leadership and strategic decision-making
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Adaptyv Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.